BDBM191629 US20240317756, Compound 25::US9181263, 25::US9278100, 25

SMILES Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CC[C@@H](NC(=O)/C=C/CN2CCOCC2)CC1

InChI Key InChIKey=QWEKIGQOBHAQDZ-UHFFFAOYSA-N

Data  15 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 15 hits for monomerid = 191629   

TargetTyrosine-protein kinase BTK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 3.48nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 3.48nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2016
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 3.48nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 25.8nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 25.8nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase Lck(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 25.8nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 273nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 273nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 273nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2016
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2016
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Pharmacyclics

US Patent
LigandChemical structure of BindingDB Monomer ID 191629BDBM191629(US9181263, 25 | US9278100, 25 | US20240317756, Com...)
Affinity DataIC50: 1.00E+4nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
US Patent